Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
First Intervention Day 0 to Week 12	STARTED	Placebo Then Etanercept	5
First Intervention Day 0 to Week 12	STARTED	Etanercept	10
First Intervention Day 0 to Week 12	COMPLETED	Placebo Then Etanercept	5
First Intervention Day 0 to Week 12	COMPLETED	Etanercept	10
First Intervention Day 0 to Week 12	NOT COMPLETED	Placebo Then Etanercept	0
First Intervention Day 0 to Week 12	NOT COMPLETED	Etanercept	0
Second Intervention Week 12 to Week 28	STARTED	Placebo Then Etanercept	5
Second Intervention Week 12 to Week 28	STARTED	Etanercept	10
Second Intervention Week 12 to Week 28	COMPLETED	Placebo Then Etanercept	5
Second Intervention Week 12 to Week 28	COMPLETED	Etanercept	10
Second Intervention Week 12 to Week 28	NOT COMPLETED	Placebo Then Etanercept	0
Second Intervention Week 12 to Week 28	NOT COMPLETED	Etanercept	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00353119/flow